Results 141 to 150 of about 53,395 (273)

The Burden of Treatment: Experiences of Patients Who Have Undergone Radiotherapy and Proton Beam Therapy. [PDF]

Healthcare (Basel)
Fairweather D, Taylor RM, Hulbert-Williams L, Hulbert-Williams NJ, Simões R.   +4 more
europepmc   +1 more source

Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer [PDF]

, 2013
Thomas J. Pugh, Mark F. Munsell, Seungtaek Choi, Q.N. Nguyen, B. Mathai, X. Ron Zhu, Narayan Sahoo, Michael T. Gillin, Jennifer L. Johnson, Richard A. Amos, Lei Dong, Usama Mahmood, Deborah A. Kuban, Steven J. Frank, Karen E. Hoffman, Sean E. McGuire, Andrew K. Lee   +16 more
openalex   +1 more source

Treatment planning evolution: Comparing approaches in photodynamic and radiation therapies

Photochemistry and Photobiology, EarlyView.
Oncological therapy based on radiation therapy (RT) is well‐developed, with widely accepted therapeutic dose concepts based on its mechanisms of action, which are applied to personalized treatment planning using sophisticated programs and tools.
Tina Saeidi, Azin Mirzajavadkhan, Lothar Lilge   +2 more
wiley   +1 more source

Updated Japanese multicenter registry study evaluates the efficacy and safety of proton beam therapy for treating extrahepatic cholangiocarcinoma. [PDF]

Sci Rep
Yamazaki H, Shibuya K, Kimoto T, Suzuki M, Murakami M, Terashima K, Okimoto T, Iizumi T, Sakurai H, Wakatsuki M, Ogino T, Arimura T, Takagi M, Araya M, Waki T, Matsumoto S, Ogino H, Katoh N, Hashimoto T, Hojo H, Fukumitsu N, Fukumoto T, Ohtsuka M.   +22 more
europepmc   +1 more source

Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types

CA: A Cancer Journal for Clinicians, EarlyView.
Abstract Reirradiation (reRT), defined as administering a course of radiation therapy to a specific area previously irradiated, is an evolving treatment strategy for locoregionally recurrent cancer that offers significant potential and poses inherent challenges.
Arnaud Beddok, Jonas Willmann, Anna Embring, Ane L. Appelt, Panagiotis Balermpas, Kevin Chua, J. Isabelle Choi, Bernice Simone Elger, Dorota Gabrys, Peter Hoskin, Maximilian Niyazi, David Pasquier, Kelly Paradis, Orit Kaidar‐Person, Corien Plaisier, Nicole C. Schmitt, Conor E. Steuer, Juliette Thariat, Sue S. Yom, Philip Poortmans, Eliana Vasquez Osorio, Nicolaus Andratschke   +21 more
wiley   +1 more source

Cone-beam computed tomography reconstruction for a commercial proton beam therapy system. [PDF]

Phys Imaging Radiat Oncol
Lindsay JWH, Meara SJP, Clarke M, Lowe M, Lines D, Aznar MC, van Herk M.   +6 more
europepmc   +1 more source

Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians

CA: A Cancer Journal for Clinicians, EarlyView.
Abstract Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer‐related death worldwide. Contemporary advances in systemic and locoregional therapies have led to changes in peer‐reviewed guidelines regarding systemic therapy as well as the possibility of downstaging disease that may enable some patients
Dimitrios Moris, Alessandro Martinino, Sarah Schiltz, Peter J. Allen, Andrew Barbas, Debra Sudan, Lindsay King, Carl Berg, Charles Kim, Mustafa Bashir, Manisha Palta, Michael A. Morse, Michael E. Lidsky   +12 more
wiley   +1 more source

Systematic Review and Meta-Analysis of Proton Beam Therapy Versus Photon Radiotherapy for Medulloblastoma: TRP-Medulloblastoma 2025. [PDF]

Cancers (Basel)
Li Y, Mizumoto M, Oshiro Y, Maruo K, Inaba M, Saito T, Hosaka S, Iizumi T, Fukushima H, Suzuki R, Nitta H, Shimizu S, Nakai K, Sakurai H.   +13 more
europepmc   +1 more source

Proton Beam Therapy for a Patient with a Giant Thymic Carcinoid Tumor and Severe Superior Vena Cava Syndrome [PDF]

, 2014
Kaori Sugawara, Masashi Mizumoto, Haruko Numajiri, Toshiki Ohno, Kayoko Ohnishi, Hitoshi Ishikawa, Toshiyuki Okumura, Hideyuki Sakurai   +7 more
openalex   +1 more source

The contemporary management of prostate cancer

CA: A Cancer Journal for Clinicians, EarlyView.
Abstract Prostate cancer is the most common cancer in two thirds of the world, with an expected doubling in both incidence and mortality in the next two decades. No strong environmental associations exist for the development of prostate cancer; therefore, lifestyle measures are unlikely to mitigate this increasing burden.
Deep Chakrabarti, Peter Albertsen, Aidan Adkins, Amar Kishan, Vedang Murthy, Chris Parker, Angela Pathmanathan, Alison Reid, Oliver Sartor, Nicholas Van As, Jochen Walz, Alison Tree   +11 more
wiley   +1 more source